INMD
InMode Ltd.NASDAQHealthcare$13.79+0.66%ClosedMarket Cap: $873.7M
As of 2026-04-06
Valuation
P/E (TTM)
9.31
PEG
—
P/B
1.27
P/S
2.34
EV/EBITDA
5.56
DCF Value
$31.96
FCF Yield
10.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.5%
Operating Margin
23.0%
Net Margin
25.3%
ROE
14.5%
ROA
12.2%
ROIC
10.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $103.9M | 78.3% | $26.0M | $27.0M | $0.42 | — |
| FY 2025 | $370.5M | 78.5% | $85.4M | $93.8M | $1.43 | — |
| Q3 2025 | $93.2M | 77.6% | $20.9M | $21.9M | $0.34 | — |
| Q2 2025 | $95.6M | 80.0% | $22.9M | $26.7M | $0.42 | — |
| Q1 2025 | $77.9M | 78.2% | $15.6M | $18.2M | $0.26 | — |
| Q4 2024 | $97.9M | 79.3% | $27.9M | $82.8M | $1.14 | — |
| FY 2024 | $394.8M | 80.3% | $112.5M | $181.3M | $2.25 | — |
| Q3 2024 | $130.2M | 81.5% | $48.3M | $51.0M | $0.65 | — |
| Q2 2024 | $86.4M | 80.2% | $18.3M | $23.8M | $0.28 | — |
| Q1 2024 | $80.3M | 79.6% | $18.1M | $23.7M | $0.28 | — |
| Q4 2023 | $126.8M | 84.0% | $51.2M | $55.2M | $0.64 | — |
| FY 2023 | $492.0M | 83.6% | $195.7M | $197.9M | $2.30 | — |